Psychopathology in Patients Diagnosed with Sars Cov 2: a Brief Report

IF 1.8 Q3 PSYCHOLOGY, CLINICAL

Mediterranean Journal of Clinical Psychology Pub Date : 2021-04-29 DOI:10.6092/2282-1619/MJCP-2982

L. Moroianu, Marius Moroianu, A. Toma, R. Barbu, V. Ardeleanu, L. Nitoi

{"title":"Psychopathology in Patients Diagnosed with Sars Cov 2: a Brief Report","authors":"L. Moroianu, Marius Moroianu, A. Toma, R. Barbu, V. Ardeleanu, L. Nitoi","doi":"10.6092/2282-1619/MJCP-2982","DOIUrl":null,"url":null,"abstract":"Background: COVID-19 is the newest and one of the most important infectious disease that became a pandemic during last year (2020) and it is caused by SARS-CoV-2 (human coronavirus), which first was diagnosed in Wuhan, China, at the end of 2019 and spreaded globally during 2020 changing our lifestyle worldwide. To evaluate the development risk of psychiatric symptoms in patients who manifested COVID 19 symptoms during the quarantine period acute phase of the disease and the aggravation of some patients` symptoms after this infectious disease. Methods: We have conducted a study on 28 patients diagnosed with SARS-CoV-2 and who have received psychopathological follow up during the quarantine through telemedicine, patients selected for a period of 3 month. Results: The average age of the patients was of 46,89 years old, with an associated standard deviation of 18,68 years and with a predominance in female gender (60,7%). 85,4% of the subjects developed psychopathologies, depending on the type of the experienced quarantine (especially home quarantine – sig = 0,042) or on the presence of sensory disorders as symptomatology (sig.=0,046). Conclusions: Adverse mental health impact has been reported in patients with SARS-CoV-2, that could be related either to the intensity of the COVID 19 symptoms (headache, cough, fever, gastrointestinal disorders, dyspnea, anosmia and ageusia) or to the disruption of personal and social healthcare and lifestyle.","PeriodicalId":18428,"journal":{"name":"Mediterranean Journal of Clinical Psychology","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2021-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mediterranean Journal of Clinical Psychology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6092/2282-1619/MJCP-2982","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}

引用次数: 8

Abstract

Background: COVID-19 is the newest and one of the most important infectious disease that became a pandemic during last year (2020) and it is caused by SARS-CoV-2 (human coronavirus), which first was diagnosed in Wuhan, China, at the end of 2019 and spreaded globally during 2020 changing our lifestyle worldwide. To evaluate the development risk of psychiatric symptoms in patients who manifested COVID 19 symptoms during the quarantine period acute phase of the disease and the aggravation of some patients` symptoms after this infectious disease. Methods: We have conducted a study on 28 patients diagnosed with SARS-CoV-2 and who have received psychopathological follow up during the quarantine through telemedicine, patients selected for a period of 3 month. Results: The average age of the patients was of 46,89 years old, with an associated standard deviation of 18,68 years and with a predominance in female gender (60,7%). 85,4% of the subjects developed psychopathologies, depending on the type of the experienced quarantine (especially home quarantine – sig = 0,042) or on the presence of sensory disorders as symptomatology (sig.=0,046). Conclusions: Adverse mental health impact has been reported in patients with SARS-CoV-2, that could be related either to the intensity of the COVID 19 symptoms (headache, cough, fever, gastrointestinal disorders, dyspnea, anosmia and ageusia) or to the disruption of personal and social healthcare and lifestyle.

查看原文本刊更多论文

Sars冠状病毒2型确诊患者的精神病理:简要报告

背景:COVID-19是去年(2020年)成为大流行的最新也是最重要的传染病之一，它是由SARS-CoV-2(人类冠状病毒)引起的，该病毒于2019年底在中国武汉首次被诊断出来，并于2020年在全球传播，改变了我们的生活方式。目的评估在隔离期间出现COVID - 19症状的患者出现精神疾病症状的风险，以及部分患者在感染后症状加重的风险。方法:选取28例确诊为SARS-CoV-2并在隔离期间接受远程医疗精神病理随访的患者为研究对象，时间为3个月。结果:患者的平均年龄为46.89岁，相关标准差为18.68岁，以女性为主(66.7%)。85,4%的受试者出现精神病理，这取决于所经历的隔离的类型(特别是家庭隔离——sig = 0,042)或作为症状的感觉障碍的存在(sig =0,046)。结论:报告了SARS-CoV-2患者的不良心理健康影响，这可能与COVID - 19症状的强度(头痛、咳嗽、发烧、胃肠道疾病、呼吸困难、嗅觉障碍和衰老)或个人和社会卫生保健和生活方式的破坏有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Mediterranean Journal of Clinical Psychology PSYCHOLOGY, CLINICAL-

CiteScore

4.10

自引率

53.80%

发文量

审稿时长

4 weeks

期刊介绍： The MJCP is an Open Access Peer-Reviewed International Journal in Clinical Psychology. MJCP accepts research related to innovative and important areas of clinical research: 1. Clinical studies related to Clinical Psychology, 2. Psychopathology and Psychotherapy; 3. Basic studies pertaining to clinical psychology field as experimental psychology, psychoneuroendocrinology and psychoanalysis; 4. Growing application of clinical techniques in clinical psychology, psychology of health, clinical approaches in projective methods; 5. Forensic psychology in clinical research; 6. Psychology of art and religion; 7. Advanced in basic and clinical research methodology including qualitative and quantitative research and new research findings.

文献相关原料

公司名称	产品信息	采购帮参考价格